Shirisha Meda

• Deepening characterization of mRNA constructs to better understand structure-function relationships and improve potency predictions, optimize design, and reduce translational risk
• Advancing mRNA drug product characterization to improve understanding, reduce variability & de-risk clinical translation

NOVEL MRNA MODALITY